Skip to main content

Advertisement

SpringerLink
Log in

Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

We assessed factors associated with mortality and complicated course in the case of Clostridium difficile infection (CDI) acquired in the intensive care unit (ICU).

Method

Retrospective cohort study conducted from 1 January 2002 through 1 January 2012. All patients who acquired CDI in our ICU were included.

Results

Thirty-one patients were included. Twenty patients (65 %) had mild colitis, 8 (25 %) moderate colitis, and 3 (10 %) severe colitis. Initial antibiotherapy was metronidazole (n = 30, 97 %) and vancomycin (n = 1, 3 %). Seventeen patients (55 %) experienced at least one complication: failure of initial treatment (n = 16, 52 %), shock (n = 11, 34 %), need for surgery (n = 1, 3 %) or renal replacement (n = 4, 13 %), or death (n = 8, 26 %). Risk factors of ICU mortality were history of corticosteroids prescription, prolonged ICU stay, low serum albumin level, and high Sequential Organ Failure Assessment (SOFA) score at the time of CDI diagnosis. Factors associated with a complicated course were high Simplified Acute Physiology Score (SAPS II), high SOFA score, and low serum albumin level at the time of CDI onset.

Conclusion

Risk factors of poor outcome in patients with CDI acquired in the ICU are different from those in the general population suffering from CDI. The implementation of treatment algorithms taking into account these factors may reduce complication rates in this specific population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T, Trévoux A, De Barbeyrac B, Boussougant Y, Tigaud S, Tytgat F, Sédallian A, Duborgel S, Collignon A, Le Guern ME, Bernasconi P, Petit JC. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med. 1996;156:1449–54.

    Article  CAS  PubMed  Google Scholar 

  2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9.

    Article  CAS  PubMed  Google Scholar 

  3. Musa SA, Moran C, Thomson SJ, Cowan ML, McAnulty G, Grounds M, Rahman TM. Clostridium difficile-associated disease acquired in the cardiothoracic intensive care unit. J Cardiothorac Vasc Anesth. 2011;25:263–7.

    Article  PubMed  Google Scholar 

  4. Ang CW, Heyes G, Morrison P, Carr B. The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK. J Infect. 2008;57:435–40.

    Article  PubMed  Google Scholar 

  5. Steering Group on Healthcare Associated Infection. Clostridium difficile infection: how to deal with the problem—a board to ward approach. London: Department of Health. 2008. http://www.hpa.org.uk/consultations/2008/cdiff.htm.

  6. Marra AR, Edmond MB, Wenzel RP, Bearman GM. Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis. 2007;7:42.

    Article  PubMed Central  PubMed  Google Scholar 

  7. McCabe WR, Jackson CG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med. 1962;110:847–55.

    Article  Google Scholar 

  8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  9. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63.

    Article  PubMed  Google Scholar 

  10. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.

    Article  CAS  PubMed  Google Scholar 

  11. Teasdale G, Jennet B. Assessment of coma and impaired consciousness. Lancet. 1974;2:81–4.

    Article  CAS  PubMed  Google Scholar 

  12. Nguyen NQ, Ching K, Fraser RJ, Chapman MJ, Holloway RH. Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance. Intensive Care Med. 2008;34:169–73.

    Article  CAS  PubMed  Google Scholar 

  13. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.

    Article  PubMed  Google Scholar 

  14. Morrison RH, Hall NS, Said M, Rice T, Groff H, Brodine SK, Slymen D, Lederman ER. Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis. 2011;53:1173–8.

    Article  PubMed  Google Scholar 

  15. Kim ES, Kim YJ, Park CW, Cho KB, Jang BK, Chung WJ, Hwang JS, Park KS. Response failure to the treatment of Clostridium difficile infection and its impact on 30-day mortality. Hepatogastroenterology. 2012;60(123). doi:10.5754/hge12730.

  16. Beaulieu M, Williamson D, Pichette G, Lachaine J. Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit. Infect Control Hosp Epidemiol. 2007;28:1305–7.

    Article  PubMed  Google Scholar 

  17. Kenneally C, Rosini JM, Skrupky LP, Doherty JA, Hollands JM, Martinez E, McKinzie WE, Murphy T, Smith JR, Micek ST, Kollef MH. Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest. 2007;132:418–24.

    Article  PubMed  Google Scholar 

  18. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007;28:123–30.

    Article  PubMed  Google Scholar 

  19. Zahar JR, Schwebel C, Adrie C, Garrouste-Orgeas M, Français A, Vesin A, Nguile-Makao M, Tabah A, Laupland K, Le-Monnier A, Timsit JF; the OUTCOMEREA study group. Outcome of ICU patients with Clostridium difficile infection. Crit Care. 2012;16:R215.

    Article  PubMed  Google Scholar 

  20. Dodek PM, Norena M, Ayas NT, Romney M, Wong H. Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit. J Crit Care. 2013 [Epub ahead of print].

  21. Johnson S. Recurrent Clostridium difficile infection: causality and therapeutic approaches. Int J Antimicrob Agents. 2009;33:S33–6.

    Article  CAS  PubMed  Google Scholar 

  22. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–7.

    Article  CAS  PubMed  Google Scholar 

  23. Musher DM, Aslam S. Treatment of Clostridium difficile colitis in the critical care setting. Crit Care Clin. 2008;24:279–91.

    Article  CAS  PubMed  Google Scholar 

  24. O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, Masur H; American College of Critical Care Medicine; Infectious Diseases Society of America. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med. 2008;36:1330–49.

    Article  PubMed  Google Scholar 

  25. Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH. Before–after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006;34:2707–13.

    Article  PubMed  Google Scholar 

  26. Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care. 2008;12:R161.

    Article  PubMed  Google Scholar 

  27. Bobo LD, Dubberke ER, Kollef M. Clostridium difficile in the ICU: the struggle continues. Chest. 2011;140:1643–53.

    Article  CAS  PubMed  Google Scholar 

  28. Wilson V, Cheek L, Satta G, Walker-Bone K, Cubbon M, Citron D, Gerding DN, Llewelyn MJ. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis. 2010;50:e77–81.

    Article  CAS  PubMed  Google Scholar 

  29. Bloomfield MG, Sherwin JC, Gkrania-Klotsas E. Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J Hosp Infect. 2012;1:1–12.

    Article  Google Scholar 

  30. Fujitani S, George WL, Murthy AR. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32:220–8.

    Article  PubMed  Google Scholar 

  31. Lungulescu OA, Cao W, Gatskevich E, Tlhabano L, Stratidis JG. CSI: a severity index for Clostridium difficile infection at the time of admission. J Hosp Infect. 2011;79:151–4.

    Article  CAS  PubMed  Google Scholar 

  32. Venugopal AA, Johnson S. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection. Clin Infect Dis. 2012;54:568–74.

    Article  PubMed  Google Scholar 

  33. Mullane KM, Miller MA, Weiss K, Lentnek A, Golan Y, Sears PS, Shue YK, Louie TJ, Gorbach SL. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis. 2011;53:440–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Service de Réanimation et Maladies Infectieuses, Hôpital Dron, 128 avenue du Président Coty, 59200, Tourcoing, France

    L. Sabau, A. Meybeck, J. Gois, N. Boussekey, P.-Y. Delannoy, A. Chiche, H. Georges & O. Leroy

  2. Département de Biostatistiques, CERIM CHRU Lille, 1 Place de Verdun, 59045, Lille Cedex, France

    P. Devos

  3. Service de Microbiologie, Hôpital Dron, 128 avenue du Président Coty, 59200, Tourcoing, France

    P. Patoz

Authors
  1. L. Sabau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Meybeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Gois
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Devos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Patoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Boussekey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P.-Y. Delannoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Chiche
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H. Georges
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. O. Leroy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Meybeck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sabau, L., Meybeck, A., Gois, J. et al. Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors. Infection 42, 23–30 (2014). https://doi.org/10.1007/s15010-013-0492-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-013-0492-1

Keywords

Search

Navigation